Clinical Trial

Analysis of Continuous Kidney Replacement Therapy (CKRT) Treatments With multiFlux Hemofilters Using Regional Citrate Anticoagulation (RCA) or Systemic Heparin Anticoagulation

Study acronym: RCA-Flux
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to assess the performance of the multiFlux hemofilterwith regional or systemic anticoagulation during CKRT treatments. The multiFlux hemofilter is a single use device within the extracorporeal blood circuit during extracorporeal blood purification treatments for acute renal replacement therapies.
Trial Details
NCT Number NCT07679568
Lead Sponsor Fresenius Medical Care Deutschland GmbH
Collaborators: Mediconomics GmbH
Conditions Acute Kidney Injury, Renal Failure
Enrollment 62 participants
Start Date 2026-07
Primary Completion 2027-06 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-07-01